Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

IGC

IGC Pharma, Inc.

Healthcare · USD

Set alert

Price alert · IGC

All alert types
0.19 USD -0.01 -7.13%
As of Oct 30, 2026 Extended hours 0.19 +2.00%
Bid
0.18 × 600
Ask
0.19 × 47,700
0.1808 Day range 0.197
0.185 52-week range 0.40
YTD
-33.93%
1 year
-53.75%
Open
0.191
Prev close
0.1992
Mkt cap
19.13M
Vol
523.10K
Avg vol
747.28K
EPS
-0.07
P/E
0.00
Div yield
0.00%
More statistics
Low
0.1808
High
0.197
Forward P/E
-3.74
Beta
1.29
Short ratio
2.29
Inst. own
22.00%
Dividend
0.00
Ex-div date
Earnings
Feb 12, 2025
50-d avg
0.3768
200-d avg
0.421
1y target
3.75

5D chart

Chart tools
Interval
1m5m15m30m
IGC five-day price chart0.080.120.170.210.26Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-18.61 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 2

Valuation

P/E -3.6×
FY 2017: -6.7×FY 2018: -9.3×FY 2019: -16.8×FY 2020: -2.6×FY 2021: -8.5×FY 2022: -3.2×FY 2023: -1.5×FY 2024: -2.2×FY 2025: -3.1×FY 2026: -3.6×
FY 2017 5y median -3.1× FY 2026
P/S 21.1×
FY 2017: 20.8×FY 2018: 7.1×FY 2019: 14.0×FY 2020: 4.8×FY 2021: 83.6×FY 2022: 119×FY 2023: 19.6×FY 2024: 20.8×FY 2025: 17.2×FY 2026: 21.1×
FY 2017 5y median 20.8× FY 2026
P/B 4.1×
FY 2017: 1.6×FY 2018: 1.9×FY 2019: 2.1×FY 2020: 0.7×FY 2021: 2.3×FY 2022: 2.0×FY 2023: 1.2×FY 2024: 3.8×FY 2025: 3.4×FY 2026: 4.1×
FY 2017 5y median 3.4× FY 2026
P/FCF -4.1×
FY 2017: -7.8×FY 2018: -7.3×FY 2019: -21.1×FY 2020: -1.5×FY 2021: -6.1×FY 2022: -5.8×FY 2023: -2.3×FY 2024: -4.9×FY 2025: -4.1×FY 2026: -4.1×
FY 2017 5y median -4.1× FY 2026
EV/EBITDA -4.0×
FY 2017: -11.6×FY 2018: -9.3×FY 2019: -10.0×FY 2020: -1.9×FY 2021: -7.4×FY 2022: -2.6×FY 2023: -1.4×FY 2024: -2.2×FY 2025: -3.3×FY 2026: -4.0×
FY 2017 5y median -2.6× FY 2026
EV/Sales 21.7×
FY 2017: 24.4×FY 2018: 7.4×FY 2019: 9.0×FY 2020: 3.1×FY 2021: 68.6×FY 2022: 94.7×FY 2023: 16.6×FY 2024: 20.2×FY 2025: 17.0×FY 2026: 21.7×
FY 2017 5y median 20.2× FY 2026
FCF Yield -24.4%
FY 2017: -12.7%FY 2018: -13.6%FY 2019: -4.7%FY 2020: -67.9%FY 2021: -16.5%FY 2022: -17.4%FY 2023: -42.9%FY 2024: -20.4%FY 2025: -24.2%FY 2026: -24.4%
FY 2017 5y median -24.2% FY 2026

Profitability

Gross Margin 29.7%
FY 2017: 37.6%FY 2018: 3.7%FY 2019: 2.6%FY 2020: 2.8%FY 2021: -38.9%FY 2022: 48.9%FY 2023: -17.3%FY 2024: 54.5%FY 2025: 48.7%FY 2026: 29.7%
FY 2017 5y median 48.7% FY 2026
Operating Margin -860.3%
FY 2017: -353.9%FY 2018: -81.6%FY 2019: -90.8%FY 2020: -168.6%FY 2021: -971.5%FY 2022: -3886.1%FY 2023: -1270.1%FY 2024: -728.5%FY 2025: -585.8%FY 2026: -860.3%
FY 2017 5y median -860.3% FY 2026
Net Margin -552.1%
FY 2017: -321.7%FY 2018: -81.4%FY 2019: -80.1%FY 2020: -179.6%FY 2021: -981.2%FY 2022: -3782.4%FY 2023: -1263.0%FY 2024: -966.5%FY 2025: -560.3%FY 2026: -552.1%
FY 2017 5y median -966.5% FY 2026
ROE -107.0%
FY 2017: -25.4%FY 2018: -22.1%FY 2019: -12.2%FY 2020: -27.6%FY 2021: -26.9%FY 2022: -62.8%FY 2023: -77.2%FY 2024: -177.6%FY 2025: -112.5%FY 2026: -107.0%
FY 2017 5y median -107.0% FY 2026
ROIC -144.8%
FY 2017: -20.6%FY 2018: -17.4%FY 2019: -13.8%FY 2020: -25.3%FY 2021: -25.7%FY 2022: -62.9%FY 2023: -75.1%FY 2024: -127.5%FY 2025: -113.0%FY 2026: -144.8%
FY 2017 5y median -113.0% FY 2026
ROA -71.3%
FY 2017: -16.5%FY 2018: -16.5%FY 2019: -11.9%FY 2020: -25.2%FY 2021: -24.6%FY 2022: -56.0%FY 2023: -67.0%FY 2024: -131.3%FY 2025: -81.4%FY 2026: -71.3%
FY 2017 5y median -71.3% FY 2026

Growth (YoY)

Revenue -6.7%
FY 2017: -90.9%FY 2018: 277.9%FY 2019: 133.3%FY 2020: -20.4%FY 2021: -77.9%FY 2022: -55.8%FY 2023: 129.5%FY 2024: 47.6%FY 2025: -5.5%FY 2026: -6.7%
FY 2017 FY 2026
Operating Income -37.0%
FY 2017: 29.3%FY 2018: 12.9%FY 2019: -159.5%FY 2020: -47.8%FY 2021: -27.1%FY 2022: -76.8%FY 2023: 25.0%FY 2024: 15.3%FY 2025: 24.0%FY 2026: -37.0%
FY 2017 FY 2026
EPS (diluted) 22.3%
FY 2017: 58.8%FY 2018: 14.3%FY 2019: -100.0%FY 2020: -58.3%FY 2021: -10.5%FY 2022: -42.9%FY 2023: 26.7%FY 2024: 0.0%FY 2025: 57.7%FY 2026: 22.3%
FY 2017 FY 2026
Free Cash Flow -15.7%
FY 2017: -449.1%FY 2018: -38.7%FY 2019: -59.0%FY 2020: -287.7%FY 2021: 5.7%FY 2022: 33.6%FY 2023: 6.9%FY 2024: 25.5%FY 2025: 7.6%FY 2026: -15.7%
FY 2017 FY 2026

Financial Health

Current Ratio 0.4×
FY 2017: 2.8×FY 2018: 1.4×FY 2019: 30.4×FY 2020: 9.1×FY 2021: 9.9×FY 2022: 6.2×FY 2023: 3.4×FY 2024: 1.6×FY 2025: 1.3×FY 2026: 0.4×
FY 2017 5y median 1.6× FY 2026
Quick Ratio 0.2×
FY 2017: 2.8×FY 2018: 1.2×FY 2019: 30.2×FY 2020: 6.9×FY 2021: 6.9×FY 2022: 4.7×FY 2023: 2.0×FY 2024: 0.9×FY 2025: 0.7×FY 2026: 0.2×
FY 2017 5y median 0.9× FY 2026
Debt / Equity 0.2×
FY 2017: 0.4×FY 2018: 0.3×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.2×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA -0.1×
FY 2017: -1.7×FY 2018: -0.3×FY 2019: 5.6×FY 2020: 1.0×FY 2021: 1.6×FY 2022: 0.7×FY 2023: 0.3×FY 2024: 0.1×FY 2025: 0.0×FY 2026: -0.1×
FY 2017 5y median 0.1× FY 2026
Interest Coverage 0.0×
FY 2017: -9.2×FY 2018: -58.2×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-03-31